Close Menu

NEW YORK (GenomeWeb) – NanoString said after the close of the market Thursday that it has signed commercial partnerships with three contract research organizations to expand commercial access to its PanCancer IO 360 Gene Expression Panel.

The deals with Covance, NeoGenomics Laboratories, and Navigate BioPharma Services will have two main areas of focus. First, NanoString will enable the CROs to offer and deliver a standardized research report that currently captures 47 gene expression signatures measuring the activity and abundance of immune and tumor cells.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.

Sponsored by

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.